In response the novel coronavirus emergency, the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) has activated its Clinical Characterisation Protocol (CCP) for emerging infections in England and Scotland.
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage. The Riley Group study was funded by the British Heart Foundation and led by BHF CRE Intermediate Transition Research Fellow Dr Filipa Sim\u00f5es.
A new study published in Nature Communications identifies a key driver of joint and intestinal inflammation that could lead to future treatment of the chronic inflammatory disease.
The severity of Zika virus-related deformations in babies has been shown to be affected by environmental factors such as maternal nutrition. The study was partially funded by a joint MRC Grant between DPAG's Professor Zolt\u00e1n Moln\u00e1r and Associate Professor Patricia Garcez of the Federal University of Rio de Janeiro.
Researchers in the Sir William Dunn School of Pathology, together with colleagues from across Oxford, have successfully obtained a structure of the surface layer from Gram-negative bacteria, bound to the cell membrane via long sugars called lipopolysaccharide or endotoxin, by applying novel electron tomography techniques.
The King Abdullah International Medical Research Centre (KAIMRC), in collaboration with the University of Oxford\u2019s Jenner Institute has started a Phase I clinical trial in the Kingdom of Saudi Arabia (KSA) for a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
A Europe-wide study conducted over three flu seasons finds that the antiviral drug, oseltamivir (Tamiflu\u00ae), can help people recover from flu-like illness about one-day sooner on average, with older, sicker patients who have been unwell for longer recovering two-to-three days sooner.
Associate Professor Ana Domingos reviews the identification of the hormone leptin and explores its significance in the function of immune cells in obesity.
A new study published in the Journal of Experimental Medicine reveals how IL-10 and PGE2 work together to prevent inflammatory tissue damage and maintain a healthy gut balance
A large field study of typhoid conjugate vaccine (TCV) in Nepal has shown a single dose to be safe and effective in reducing typhoid in children aged 9 months to <16 years in an endemic setting.
The emergence of untreatable strains of typhoid threatens a new global health emergency that requires urgent collective action, argue experts from the Oxford Martin School in the journal Clinical Infectious Diseases today.
Following the publication of figures showing UK childhood vaccination rates have fallen for the fifth year in a row, researchers from OVG and the Oxford Martin Programme on Collective Responsibility for Infectious Disease discuss possible responses.
New research from Dr Richard Williams\u2019 group at the Kennedy Institute suggests a route for the development of more selective \u2013 and effective \u2013 therapies for immune-mediated inflammatory disease.
Researchers from the University of Oxford teamed up with the Angolan Ministry of Health to study the introduction and circulation of the Asian genotype of Zika virus in Angola, southwestern Africa. The Asian genotype caused the 2015-16 epidemic of microcephaly and other birth defects in the Americas.
Craig MacLean, Professor of Evolution and Microbiology at Oxford's Department of Zoology, explains how evolutionary biology can help us to get rid of antibiotic resistant bacteria.
![\"Coronavirus\"](\"https://www.immunology.ox.ac.uk/news/international-research-consortium-activates-ncov-clinical-study/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n